• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大嗜铬细胞瘤(>6厘米)的外科治疗:一项为期10年的单中心经验。

Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience.

作者信息

Zhang Liang, Chen Danlei, Pang Yingxian, Guan Xiao, Xu Xiaowen, Wang Cikui, Xiao Qiao, Liu Longfei

机构信息

Department of Urology, Xiangya Hospital, Central South University, Changsha, China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

出版信息

Asian J Urol. 2022 Jul;9(3):294-300. doi: 10.1016/j.ajur.2022.04.004. Epub 2022 Jun 20.

DOI:10.1016/j.ajur.2022.04.004
PMID:36035344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9399532/
Abstract

OBJECTIVE

Clinical practice guidelines recommend open adrenalectomy (OA) for large pheochromocytoma (LPCC) > 6 cm in size. Although laparoscopic adrenalectomy (LA) for the treatment of LPCC has been reported, its role remains unclear. This study aimed to compare the effectiveness of LA and OA, and summary the surgical treatment experience.

METHODS

Data concerning LPCC, from January 2010 to June 2019 of a single institution, were retrospectively reviewed. Altogether 82 patients with a tumor larger than 6 cm were included (52 patients in LA group and 30 patients in OA group). Groups were balanced by propensity score matching (PSM) into 15 pairs. Patients' demographics, preoperative characteristics, and prognosis were analyzed.

RESULTS

Before PSM, the OA group had larger tumor sizes (median [interquartile range, IQR]: 8.9 [7.3-10.3] 7.2 [6.7-8.0] cm; =0.000) and higher vanillylmandelic acid level (median [IQR]: 114.3 [67.8-326.4] 66.6 [37.8-145.8] μmol/24 h;  =0.004) and needed a higher cumulative dose of prazosin (median [IQR]: 83.5 [37.0-154.0] 38.0 [21.0-81.0] mg; =0.028). After PSM, the baseline data showed no significant differences between both groups. The LA group had relatively more stable blood pressure in surgery, with a lower fluctuation of systolic blood pressure (mean±standard deviation [SD]: 70.9±25.1 107.4±46.2 mmHg, =0.012) and a lower percentage of hemodynamic instability (46.7% 86.7%, =0.020). The LA group had shorter postoperative hospital stays (mean±SD: 6.4±2.7 10.1±3.4 days; =0.003) than the OA group. Differences regarding metastasis rate (6.7% 0, =1.000) were not statistically significant between LA and OA groups. The median (IQR) follow-up time of 82 patients was 72.5 (47.0-103.5) months. Binary logistic regression showed that right-side tumors or those >8 cm in size were independent risk factors of OA.

CONCLUSION

LA is a safe, minimally invasive procedure for LPCC and has relatively better perioperative characteristics in large medical centers. Patients with tumors on the right side or larger than 8 cm are more likely to undergo OA initially.

摘要

目的

临床实践指南推荐对直径大于6cm的大嗜铬细胞瘤(LPCC)行开放性肾上腺切除术(OA)。虽然已有关于腹腔镜肾上腺切除术(LA)治疗LPCC的报道,但其作用仍不明确。本研究旨在比较LA和OA的有效性,并总结手术治疗经验。

方法

回顾性分析2010年1月至2019年6月某单一机构中有关LPCC的数据。共纳入82例肿瘤直径大于6cm的患者(LA组52例,OA组30例)。通过倾向评分匹配(PSM)将两组患者均衡匹配为15对。分析患者的人口统计学资料、术前特征及预后情况。

结果

PSM前,OA组肿瘤直径更大(中位数[四分位数间距,IQR]:8.9[7.3 - 10.3]对7.2[6.7 - 8.0]cm;P = 0.000),香草扁桃酸水平更高(中位数[IQR]:114.3[67.8 - 326.4]对66.6[37.8 - 145.8]μmol/24小时;P = 0.004),且需要更高的哌唑嗪累积剂量(中位数[IQR]:83.5[37.0 - 154.0]对38.0[21.0 - 81.0]mg;P = 0.028)。PSM后,两组的基线数据无显著差异。LA组手术过程中血压相对更稳定,收缩压波动更低(均值±标准差[SD]:70.9±25.1对'107.4±46.2mmHg,P = 0.012),血流动力学不稳定的百分比更低(46.7%对86.7%,P = 0.020)。LA组术后住院时间比OA组短(均值±SD:6.4±2.7对10.1±3.4天;P = (此处原文有误,推测应为P = 0.003))。LA组和OA组的转移率差异(6.7%对0,P = 1.000)无统计学意义。82例患者的中位(IQR)随访时间为72.5(47.0 - 103.5)个月。二元逻辑回归显示右侧肿瘤或直径大于8cm的肿瘤是OA的独立危险因素。

结论

LA是治疗LPCC的一种安全且微创的手术方法,在大型医疗中心具有相对更好围手术期特征。右侧肿瘤或直径大于8cm的患者最初更可能接受OA手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d00/9399532/cfba42b2c47a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d00/9399532/cfba42b2c47a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d00/9399532/cfba42b2c47a/gr1.jpg

相似文献

1
Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience.大嗜铬细胞瘤(>6厘米)的外科治疗:一项为期10年的单中心经验。
Asian J Urol. 2022 Jul;9(3):294-300. doi: 10.1016/j.ajur.2022.04.004. Epub 2022 Jun 20.
2
Comparison of transperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: A retrospective propensity score-matched cohort study.经腹腔腹腔镜与开放性肾上腺切除术治疗大嗜铬细胞瘤的比较:一项回顾性倾向评分匹配队列研究。
Int J Surg. 2019 Jan;61:26-32. doi: 10.1016/j.ijsu.2018.11.018. Epub 2018 Nov 29.
3
Comparison of retroperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: a single-center retrospective study.后腹腔镜与开放肾上腺切除术治疗大型嗜铬细胞瘤的比较:单中心回顾性研究。
World J Surg Oncol. 2019 Jun 29;17(1):111. doi: 10.1186/s12957-019-1649-x.
4
Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): A systematic review and meta-analysis.腹腔镜肾上腺切除术(LA)与开放肾上腺切除术(OA)治疗嗜铬细胞瘤(PHEO):系统评价和荟萃分析。
Eur J Surg Oncol. 2020 Jun;46(6):991-998. doi: 10.1016/j.ejso.2020.02.009. Epub 2020 Feb 17.
5
Laparoscopic adrenalectomy for pheochromocytoma: evaluation of experience and strategy at a single institute.腹腔镜肾上腺切除术治疗嗜铬细胞瘤:单机构经验与策略评估
BJU Int. 2009 Jan;103(2):218-22. doi: 10.1111/j.1464-410X.2008.07894.x. Epub 2008 Jul 29.
6
Risk factors affecting operative approach, conversion, and morbidity for adrenalectomy: a single-institution series of 402 patients.影响肾上腺切除术手术入路、中转和发病率的风险因素:单机构 402 例系列研究。
Surg Endosc. 2013 Jul;27(7):2342-50. doi: 10.1007/s00464-013-2789-7. Epub 2013 Feb 13.
7
Laparoscopic vs. open adrenalectomy: perioperative data and survival analysis in 70 dogs with an adrenal tumor.腹腔镜与开放肾上腺切除术:70只患有肾上腺肿瘤犬的围手术期数据及生存分析
Front Vet Sci. 2023 Aug 16;10:1156801. doi: 10.3389/fvets.2023.1156801. eCollection 2023.
8
Laparoscopic Treatment of Large Adrenal Tumor is Safe and Effective? A Single Center Experiences.腹腔镜治疗大型肾上腺肿瘤是否安全有效?单中心经验。
J Invest Surg. 2021 Sep;34(9):957-962. doi: 10.1080/08941939.2020.1719243. Epub 2020 Feb 9.
9
Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study.机器人辅助与腹腔镜肾上腺切除术治疗嗜铬细胞瘤:一项国际多中心研究
Eur Urol Focus. 2025 Jan;11(1):118-125. doi: 10.1016/j.euf.2024.09.001. Epub 2024 Sep 14.
10
Laparoscopic adrenalectomy: a new standard of care.腹腔镜肾上腺切除术:一种新的治疗标准。
Urology. 1997 May;49(5):673-8. doi: 10.1016/s0090-4295(97)00083-6.

本文引用的文献

1
Controversies about the systematic preoperative pharmacological treatment before pheochromocytoma or paraganglioma surgery.关于嗜铬细胞瘤或副神经节瘤手术前系统药物治疗的争议。
Eur J Endocrinol. 2022 Mar 18;186(5):D17-D24. doi: 10.1530/EJE-21-0692.
2
Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance.嗜铬细胞瘤与腹部副神经节瘤:实用指南
Cancers (Basel). 2022 Feb 12;14(4):917. doi: 10.3390/cancers14040917.
3
Selective vs non-selective alpha-blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta-analysis.
嗜铬细胞瘤肾上腺切除术之前选择性与非选择性α受体阻滞:系统评价与荟萃分析
Eur J Endocrinol. 2021 May 4;184(6):751-760. doi: 10.1530/EJE-20-1301.
4
Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤患者血流动力学不稳定的预测因素。
J Surg Oncol. 2020 Sep;122(4):803-808. doi: 10.1002/jso.26079. Epub 2020 Jun 20.
5
Clinical and genetic features of pediatric PCCs/PGLs patients: a single-center experience in China.儿童嗜铬细胞瘤/副神经节瘤患者的临床和遗传特征:中国单中心经验
Transl Androl Urol. 2020 Apr;9(2):267-275. doi: 10.21037/tau.2020.02.14.
6
Large Malignant Pheochromocytoma Causing Cardiac Failure and Metastasis: A Case Report With Review of Literature.巨大恶性嗜铬细胞瘤致心脏衰竭和转移:病例报告并文献复习。
Curr Probl Diagn Radiol. 2021 Nov-Dec;50(6):961-966. doi: 10.1067/j.cpradiol.2020.03.001. Epub 2020 Apr 8.
7
The systems of metastatic potential prediction in pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤转移潜能预测系统。
Am J Cancer Res. 2020 Mar 1;10(3):769-780. eCollection 2020.
8
Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): A systematic review and meta-analysis.腹腔镜肾上腺切除术(LA)与开放肾上腺切除术(OA)治疗嗜铬细胞瘤(PHEO):系统评价和荟萃分析。
Eur J Surg Oncol. 2020 Jun;46(6):991-998. doi: 10.1016/j.ejso.2020.02.009. Epub 2020 Feb 17.
9
Risk factors for open conversion of lateral transperitoneal laparoscopic adrenalectomy: retrospective cohort study of the Spanish Adrenal Surgery Group (SASG).经侧腹膜腹腔镜肾上腺切除术转为开放手术的危险因素:西班牙肾上腺外科学组(SASG)的回顾性队列研究
Surg Endosc. 2020 Aug;34(8):3690-3695. doi: 10.1007/s00464-019-07264-1. Epub 2019 Nov 21.
10
Pheochromocytoma and Paraganglioma.嗜铬细胞瘤和副神经节瘤。
N Engl J Med. 2019 Aug 8;381(6):552-565. doi: 10.1056/NEJMra1806651.